KV Pharmaceutical, Purdue Pharma settle painkiller patent dispute - Business First of Buffalo:

lyubomiradete.blogspot.com
Under the settlement, KV agreedd to no longer dispute the enforceabilityor infringement” of the Purdue generic oxycodone patents. In return, Purdue granted KV a limited, non-exclusive licensre to manufactureand sell, in the Unitedx States, a certain amount of various dosage strengths of the drugws as long as KV pays royalties to KV also reached a deal to be an authorized, non-exclusivs distributor in the United States of certain generic versionsa of OxyContin. These agreements settlee three patent infringementlawsuitsx Stamford, Conn.-based Purdue filed againstr KV in 2007. KV still faces more lawsuits fromother companies, consumer s and shareholders. Three individuals in St.
Claier County Circuit Court against KV, alleging that certaim drugs contained a potentially lethap amount of morphine due to oversized tablets that were eventually recalled by the pharmaceutical Last month, , a Florida-baseed dermatology company, sued KV, of a patenrt for Duac topical gel, an acne KV also faces lawsuits from shareholders about manufacturingg compliance and the company’s financial prospects. Brentwood, Mo.-basex KV has and recalled painkillers. In KV said it with the FDA that outlines a seriee of measures that will permit KV and its subsidiariews to resume manufacturingand distribution.